ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Antitumor Activity and Safety of Trastuzumab Deruxtecan in Patients With HER2-Low-Expressing Advanced Breast Cancer: Results From a Phase Ib Study.

Shanu Modi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.